A phase 3 trial of SI-B001 and docetaxel in lung cancer, run by Sichuan Baili Pharmaceutical Co., Ltd., active but no longer recruiting.
A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell Lung Adenocarcinoma and Lung Squamous Cell Carcinoma is a phase 3, randomised interventional study registered as NCT05943795 by Sichuan Baili Pharmaceutical Co., Ltd., with a registry enrolment figure of 589 participants, started 2023-07-14 and due to reach its primary completion in 2026-07. Interventions recorded: SI-B001; Docetaxel. Conditions listed: Non-small Cell Lung Adenocarcinoma; Squamous Cell Carcinoma of Lung. Primary outcome: Overall survival (OS); Progression-free survival (PFS). Lung eligibility wording from the registry: "Patients with histologically or cytologically confirmed locally advanced or metastatic non-small cell lung cancer;". Sites: China. No results are recorded here; the registry entry is the source.
Shares Squamous cell carcinoma of the lung, Docetaxel, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Squamous cell carcinoma of the lung, SystImmune / Sichuan Biokin, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Squamous cell carcinoma of the lung, Docetaxel, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Squamous cell carcinoma of the lung, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Docetaxel, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Docetaxel, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Squamous cell carcinoma of the lung, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Squamous cell carcinoma of the lung, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.